Milana Chamberlain and George Cameron ask: is it time for pharma to start using human rights language?
Milan Chamberlain and George Cameron
Advertisement
Milan Chamberlain is a Partner specialising in business and human rights and George Cameron is Of Counsel in the Life Sciences and Healthcare group at Norton Rose Fulbright.
Articles by Milan Chamberlain and George Cameron
Advertisement
Latest Updated Articles
Human Rights on the Pharma Risk Management AgendaPublished: November 3rd 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
